FENC
NASDAQ HealthcareFennec Pharmaceuticals Inc. - Common Stock
Biotechnology
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
�� 市场数据
| 价格 | $6.79 |
|---|---|
| 成交量 | 216,495 |
| 市值 | 234.09M |
| 贝塔系数 | 0.930 |
| RSI（14日） | 64.1 |
| 200日均线 | $8.09 |
| 50日均线 | $7.43 |
| 52周最高 | $9.92 |
| 52周最低 | $5.02 |
| Forward P/E | 7.37 |
| Price / Book | 6.54 |
🎯 投资策略评分
FENC 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🔪 Falling Knife (84/100) — 此策略 逆向投资（超卖 + 低于移动均线）.
评分最低的策略： 🐋 Institutional Whale (4/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 FENC in your text
粘贴任何文章、记录或帖子 — 工具将提取 FENC 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-04-17.